通过向COX-2/PGE2通路,打破乳腺癌中的免疫逃避
Xuewei Zheng1, Junxiang Wang1, Yanan OuYang2
1Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, 471003, China.
循环氧化酶-2 (COX-2) /前列腺素E2 (PGE2) 途径促进乳腺癌的进展和免疫抑制. 针对这一轴,特别是通过双重EP2/EP4抑制或联合疗法,提供了增强抗瘤免疫力和改善治疗结果的有希望的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环氧化酶-2 (COX-2) /前列腺素E2 (PGE2) 途径是乳腺癌 (BC) 进展的组成部分,驱动免疫抑制,瘤生长和转移.
- PGE2通过EP受体 (EP1-EP4) 发挥其作用,通过招募免疫抑制细胞和损害抗瘤免疫细胞功能来促进免疫抑制瘤微环境 (TME).
研究的目的:
- 审查乳腺癌中COX-2/PGE2通路的免疫抑制机制.
- 探索针对这一轴的新型治疗策略,以改善BC治疗,特别是与免疫疗法结合使用.
主要方法:
- 关于研究乳腺癌中COX-2/PGE2通路的文献综述.
- 治疗策略的分析,包括EP受体对抗性,15-基前列腺素脱酶 (15-PGDH) 增强,以及与免疫检查点抑制剂 (ICI) 结合治疗.
主要成果:
- 与单一阻断相比,EP2和EP4受体的双重抑制在逆转免疫抑制方面表现出更高的有效性.
- 将EP4抗剂与ICI (抗PD-1,抗CTLA-4) 结合起来,可以增强T细胞透和抗瘤活性.
- 增强15-PGDH活性或抑制PTGES1可以抵消PGE2驱动的免疫逃避并克服TME抑制.
结论:
- 准COX-2/PGE2轴是治疗乳腺癌的一个有希望的策略.
- 组合疗法,特别是与免疫检查点抑制剂的组合疗法,具有显著的潜力,可以提高治疗结果.
- 需要进一步的研究,包括TIL分层试验,以优化针对BC.的COX-2/PGE2通路的免疫治疗策略.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Mitogens and the Cell Cycle
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
